Pat Placzek, 34, was diagnosed with leukemia mere months after successfully completing treatment for epithelial sarcoma. The illness forced him to suspend his MES in Planning at York University.
After five rounds of aggressive chemotherapy within less than a year, Pat received a stem cell transplant from his brother, Dan, in December. The procedure took a heavy toll on his health, as Pat dealt with intense pain and discomfort. Still, Pat’s infectious smile never left him.
Unfortunately, the transplant was not successful. Just two months after receiving the transplant, a blood test detected cancer cells yet again.
Pat’s last chance at recovery is an experimental treatment, called chimeric antigen receptor (CAR) T-cell therapy, at Fred Hutchinson Cancer Research Centre in Seattle.
In early trials, CAR T-cell therapy has had a success rate of 90 percent for refractory Acute Lymphoblastic Leukemia. The FDA has designated it a “breakthrough” therapy.
Pat and his family have been told the total cost of taking part in the treatment will be $420,000 USD (~$530,000 CDN).
We want nothing more than to continue to share in Pat’s laughter, gentle spirit and creativity for decades to come.
Please help us help Pat and his family through these difficult times. Every little bit counts, and time is of the essence.